EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

N‐palmitoyl‐ d ‐glucosamine limits mucosal damage and VEGF ‐mediated angiogenesis by PPARα ‐dependent suppression of pAkt / mTOR / HIF1α pathway and increase in PEA levels in AOM / DSS colorectal carcinoma in mice

Irene Palenca, Silvia Basili Franzin, Aurora Zilli, Luisa Seguella, Anna Troiani, Federico Pepi, Martina Vincenzi, Giuseppe Giugliano, Viviana Catapano, Italia Di Filippo, Giovanni Sarnelli, Giuseppe Esposito iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8303 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Irene Palenca and 11 co-authors. Institution: Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy. Major MEDLINE topics: TOR Serine-Threonine Kinases, PPAR alpha, Hypoxia-Inducible Factor 1, alpha Subunit, Colorectal Neoplasms. Cited 9 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Chronic intestinal inflammation and neo‐angiogenesis are interconnected in colorectal carcinoma (CRC) pathogenesis. Molecules reducing inflammation and angiogenesis hold promise for CRC prevention and treatment. N‐Palmitoyl‐ d ‐glucosamine (PGA), a natural glycolipid analog with anti‐inflammatory properties, has shown efficacy against acute colitis. Micronized PGA (mPGA) formulations exhibit superior anti‐inflammatory activity. This study investigates the in vivo anti‐angiogenic and protective effects of mPGA in a mouse model of colitis‐associated CRC induced by azoxymethane/dextran sodium sulfate (AOM/DSS). CRC was induced in C57BL/6J mice using intraperitoneal azoxymethane followed by three cycles of 2.5% dextran sodium sulfate (DSS) in drinking water. Mice were treated with mPGA (30–150 mg/kg) with or without the PPARα inhibitor MK886 (10 mg/kg). At Day 70 post‐azoxymethane injection, mice underwent anesthetized endoscopic colon evaluation. Post‐mortem analysis of tumorigenesis and angiogenesis was performed using histological, immunohistochemical, and immunoblotting techniques. mPGA improved disease progression and survival rates in a dose‐ and PPARα‐dependent manner in AOM/DSS‐exposed mice. It reduced polyp formation, decreased pro‐angiogenic CD31, pro‐proliferative Ki67, and pro‐inflammatory TLR4 expression levels, and inhibited VEGF and MMP‐9 secretion by disrupting the pAkt/mTOR/HIF1α pathway. mPGA increased colon PEA levels, restoring anti‐tumoral PPARα and wtp53 protein expression. Given its lack of toxicity, mPGA shows potential as a nutritional intervention to counteract inflammation‐related angiogenesis in CRC.

Subjects

MeSH terms (MEDLINE)

TOR Serine-Threonine KinasesPPAR alphaHypoxia-Inducible Factor 1, alpha SubunitColorectal NeoplasmsMice, Inbred C57BLVascular Endothelial Growth Factor AAzoxymethaneNeovascularization, PathologicAnimalsMiceMaleDextran SulfateProto-Oncogene Proteins c-aktSignal TransductionColitisDisease Models, AnimalIntestinal MucosaGlucosamineAngiogenesis

Author keywords

ALIAmidesVEGFangiogenesiscolorectal carcinomamPGApAkt/mTOR/HIF1α

Substances

TOR Serine-Threonine KinasesPPAR alphaHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor AAzoxymethanemTOR protein, mouseDextran SulfateProto-Oncogene Proteins c-aktHif1a protein, mousevascular endothelial growth factor A, mouse

Authors and institutions

  • Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.
  • Department of Chemistry and Drug Technologies, Sapienza University of Rome, Rome, Italy.
  • Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.

ORCID profiles: Giuseppe Esposito

Cite

APA

Palenca, I., Basili Franzin, S., Zilli, A., Seguella, L., Troiani, A., Pepi, F., Vincenzi, M., Giugliano, G., Catapano, V., Di Filippo, I., Sarnelli, G., & Esposito, G. (2024). N‐palmitoyl‐ d ‐glucosamine limits mucosal damage and VEGF ‐mediated angiogenesis by PPARα ‐dependent suppression of pAkt / mTOR / HIF1α pathway and increase in PEA levels in AOM / DSS colorectal carcinoma in mice. Phytotherapy Research. https://doi.org/10.1002/ptr.8303

Vancouver

Palenca I, Basili Franzin S, Zilli A, Seguella L, Troiani A, Pepi F, et al. N‐palmitoyl‐ d ‐glucosamine limits mucosal damage and VEGF ‐mediated angiogenesis by PPARα ‐dependent suppression of pAkt / mTOR / HIF1α pathway and increase in PEA levels in AOM / DSS colorectal carcinoma in mice. Phytotherapy Research. 2024. doi:10.1002/ptr.8303

BibTeX
@article{Palenca2024,
  author = {Palenca, Irene and Basili Franzin, Silvia and Zilli, Aurora and Seguella, Luisa and Troiani, Anna and Pepi, Federico and Vincenzi, Martina and Giugliano, Giuseppe and Catapano, Viviana and Di Filippo, Italia and Sarnelli, Giovanni and Esposito, Giuseppe},
  title = {N‐palmitoyl‐ d ‐glucosamine limits mucosal damage and VEGF ‐mediated angiogenesis by PPARα ‐dependent suppression of pAkt / mTOR / HIF1α pathway and increase in PEA levels in AOM / DSS colorectal carcinoma in mice},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8303}
}
Start for free →